Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gender effect on effective propofol target plasma concentration for laryngeal mask airway insertion with dexmedetomidine
ChiCTR-OCH-14004897Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and dexmedetomidine (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Whether responses to laryngeal mask airway insertion occur. Started Jul 2014; status: recruiting.
02
Drugs
propofoldexmedetomidine
Beyond the preview
Go deeper on ChiCTR-OCH-14004897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004897.